Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc. (BBIO), sold 36,432 shares at $64.82 ($2.4M) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Scheduled sale ($2.4M) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.13 | 22,781 | $1.5M | 62.9% |
| 2 | $64.82 | 10,456 | $678K | 28.3% |
| 3 | $65.95 | 3,195 | $211K | 8.8% |
| Total | $65.74 avg | 36,432 | $2.4M | 100% |
| Filing → |
| BBIO | SELL | 2025-08-22 | $4.2M | — | Filing → |
| BBIO | SELL | 2025-08-19 | $1.7M | — | Filing → |